NASDAQ : IMCR

Immunocore Holdings plc — Financial statements

Healthcare · Biotechnology · United Kingdom

Last price 30.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.57B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Immunocore Holdings plc (IMCR) reported revenue of 430.77M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue430.77M400.02M310.20M249.43M174.36M36.48M
Revenue430.77M400.02M310.20M249.43M174.36M36.48M
Cost of Revenue289.19M279.96M224.88M164.58M6.40M100.25M
Gross Profit141.59M120.06M85.32M84.85M167.96M-63.76M
Selling, General & Admin164.16M165.41M155.78M144.50M123.06M110.82M
Research & Development96.61M
Other Operating Expenses-19.73M-19.73M-18.05M897.00K-7.00K73.00K
Operating Expenses144.44M145.69M137.73M145.39M219.66M110.90M
Operating Income-2.85M-25.62M-52.41M-60.55M-51.70M-174.66M
Interest Expense-12.21M-12.17M-18.84M-5.15M-5.41M-5.57M
Interest & Investment Income15.03M16.48M25.62M17.99M3.76M65.00K
Currency Exchange Gain (Loss)2.61M2.21M-3.45M-13.18M14.16M289.00K
EBT Excluding Unusual Items2.58M-19.10M-49.08M-60.89M-39.20M-179.88M
Gain (Loss) on Sale of Investments-5.32M
Other Unusual Items-3.85M-1.69M
Pretax Income-2.73M-19.10M-52.94M-60.89M-40.88M-179.88M
Income Tax Expense15.34M16.41M-1.85M-5.60M11.66M150.00K
Net Income-18.07M-35.51M-51.09M-55.29M-52.54M-180.03M
Net Income to Common-18.07M-35.51M-51.09M-55.29M-52.54M-180.03M
Shares Outstanding (Basic)50.68M50.35M49.99M48.89M45.71M42.49M
Shares Outstanding (Diluted)50.68M50.35M49.99M48.89M45.71M42.49M
EPS (Basic)-0.36-0.71-1.02-1.13-1.15-4.24
EPS (Diluted)-0.36-0.71-1.02-1.13-1.15-4.24
Free Cash Flow-41.15M-15.05M20.89M-2.48M-51.41M-144.49M
Free Cash Flow Per Share-0.81-0.300.42-0.05-1.12-3.40
Gross Margin32.87%30.01%27.51%34.02%96.33%-174.77%
Operating Margin-0.66%-6.41%-16.89%-24.27%-29.65%-478.73%
Profit Margin-4.20%-8.88%-16.47%-22.17%-30.14%-493.45%
Free Cash Flow Margin-9.55%-3.76%6.73%-1.00%-29.49%-396.04%
EBITDA756.00K-22.36M-48.21M-56.46M-46.37M-167.07M
EBITDA Margin0.18%-5.59%-15.54%-22.63%-26.59%
D&A For EBITDA3.61M3.27M4.20M4.09M5.33M7.59M
EBIT-2.85M-25.62M-52.41M-60.55M-51.70M-174.66M
EBIT Margin-0.66%-6.41%-16.89%-24.27%-29.65%
Revenue as Reported430.77M400.02M310.20M249.43M174.36M36.48M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents484.92M467.71M455.73M442.63M402.47M322.11M
Short-Term Investments395.29M396.44M364.64M
Cash & Short-Term Investments880.21M864.15M820.38M442.63M402.47M322.11M
Accounts Receivable95.35M73.98M63.01M52.09M33.58M8.19M
Other Receivables27.14M20.09M9.34M23.50M15.03M
Receivables95.35M101.12M83.10M61.44M57.08M23.22M
Inventory7.79M6.74M5.45M4.50M692.00K
Prepaid Expenses67.69M17.98M13.05M10.55M10.11M10.41M
Other Current Assets6.75M7.90M9.71M3.62M
Total Current Assets1.05B996.74M929.86M528.82M473.98M355.75M
Property, Plant & Equipment49.88M50.24M47.73M42.73M38.78M42.70M
Long-Term Deferred Tax Assets14.79M10.97M5.12M3.49M
Other Long-Term Assets18.50M20.28M17.12M14.47M8.89M6.68M
Total Assets1.12B1.07B1.01B597.00M526.76M408.62M
Accounts Payable26.32M24.36M25.10M17.80M14.45M10.15M
Accrued Expenses196.78M202.60M180.77M115.48M73.09M37.11M
Current Portion of Leases1.91M2.01M1.55M1.39M1.88M1.70M
Current Income Taxes Payable1.12M720.36K
Current Unearned Revenue573.00K583.00K7.76M33.11M
Other Current Liabilities9.62M17.14M4.76M4.36M2.54M52.81K
Total Current Liabilities235.20M246.70M212.18M139.02M100.83M82.84M
Long-Term Debt394.21M393.12M391.01M48.01M47.81M50.41M
Long-Term Leases38.85M41.56M40.16M35.61M31.76M34.33M
Long-Term Unearned Revenue4.49M4.86M5.43M5.51M5.24M8.68M
Other Long-Term Liabilities26.88M2.21M77.18K
Total Liabilities699.62M686.24M648.79M228.16M187.86M176.33M
Common Stock138.00K136.00K135.00K134.00K129.00K119.16K
Additional Paid-In Capital1.27B1.24B1.19B1.15B1.08B287.38M
Retained Earnings-819.11M-831.27M-795.76M-744.67M-689.39M-651.83M
Comprehensive Income & Other-34.33M-28.08M-33.76M-36.26M-54.67M596.62M
Shareholders' Equity419.80M381.03M360.72M368.84M338.90M232.28M
Total Liabilities & Equity1.12B1.07B1.01B597.00M526.76M408.62M
Total Debt434.96M436.69M432.72M85.01M81.45M86.44M
Net Cash (Debt)445.25M427.47M387.65M357.62M321.02M235.67M
Net Cash Per Share8.788.497.757.317.025.55
Filing Date Shares Outstanding51.50M50.70M50.07M49.82M48.12M43.86M
Total Common Shares Outstanding51.48M50.69M50.06M49.73M48.09M43.86M
Working Capital815.85M750.04M717.68M389.80M373.14M272.91M
Book Value Per Share8.157.527.207.427.055.30
Tangible Book Value419.80M381.03M360.72M368.84M338.90M232.28M
Tangible Book Value Per Share8.157.527.207.427.055.30
Machinery48.71M43.92M41.46M33.98M36.29M
Construction In Progress1.13M477.00K46.00K431.00K21.66K
Leasehold Improvements22.42M21.02M20.02M19.09M21.18M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-18.07M-35.51M-51.09M-55.29M-52.54M-180.03M
Depreciation & Amortization3.61M3.27M4.20M4.09M5.33M7.59M
Loss (Gain) From Sale of Investments-14.41M-19.73M-14.58M
Stock-Based Compensation33.88M37.70M34.19M32.47M32.89M48.89M
Other Operating Activities10.95M12.87M4.38M10.04M-10.72M2.40M
Change in Accounts Receivable-26.55M-7.34M-12.35M-17.87M-26.26M-4.86M
Change in Accounts Payable2.30M-2.46M7.27M2.62M4.91M1.47M
Change in Unearned Revenue-582.00K-387.00K-1.00K-8.01M-25.50M-29.07M
Change in Other Net Operating Assets-26.08M879.00K54.03M34.88M22.69M10.50M
Operating Cash Flow-34.96M-10.71M26.06M2.94M-49.21M-143.11M
Capital Expenditures-6.20M-4.34M-5.17M-5.42M-2.20M-1.39M
Sale of Property, Plant & Equipment44.00K6.00K106.00K
Investment in Securities14.00M-12.00M-350.00M
Investing Cash Flow7.80M-16.34M-355.13M-5.42M-2.20M-1.28M
Long-Term Debt Issued402.50M50.00M
Long-Term Debt Repaid-52.06M-52.00M
Net Debt Issued (Repaid)350.44M-2.00M
Issuance of Common Stock23.29M12.37M6.80M34.35M149.21M288.19M
Other Financing Activities-13.36M-1.77M
Financing Cash Flow23.29M12.37M343.88M34.35M145.44M288.19M
Foreign Exchange Rate Adjustments849.00K26.66M-1.71M8.29M-12.65M625.00K
Net Cash Flow-3.01M11.98M13.11M40.15M81.39M144.42M
Free Cash Flow-41.15M-15.05M20.89M-2.48M-51.41M-144.49M
Free Cash Flow Margin-9.55%-3.76%6.73%-1.00%-29.49%-396.04%
Free Cash Flow Per Share-0.81-0.300.42-0.05-1.12-3.40
Levered Free Cash Flow35.59M23.96M38.39M14.06M-19.73M-50.31M
Unlevered Free Cash Flow43.22M31.56M50.17M17.28M-16.35M-46.83M
Free Cash Flow After Leases-41.15M-15.05M20.89M-2.48M-51.41M-144.49M
Cash Income Tax Paid3.89M4.64M510.00K977.00K765.00K-17.04M
Change in Working Capital-50.90M-9.30M48.95M11.62M-24.16M-21.96M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.57B1.75B1.48B3.38B2.73B1.50B
Enterprise Value1.12B1.30B1.06B3.02B2.43B1.24B
Last Close Price30.4934.7129.5068.3257.0734.24
PS Ratio3.654.384.7613.5415.6841.15
PB Ratio3.744.604.099.168.076.46
P/TBV Ratio3.744.604.099.168.076.46
P/FCF Ratio70.66
P/OCF Ratio56.631,148.85
EV/Sales Ratio2.613.243.4012.1113.9334.05
EV/FCF Ratio50.54
Debt / Equity Ratio1.041.151.200.230.240.37
Debt / FCF Ratio20.72
Net Debt / Equity Ratio-1.06-1.12-1.07-0.97-0.95-1.01
Net Debt / EBITDA Ratio-588.9619.128.046.336.921.41
Net Debt / FCF Ratio10.8228.40-18.56143.916.241.63
Asset Turnover0.390.390.390.440.370.11
Inventory Turnover43.6645.9445.2263.39
Quick Ratio4.153.914.263.634.564.17
Current Ratio4.474.044.383.804.704.29
Return on Equity (ROE)-4.47%-9.58%-14.01%-15.62%-18.40%-117.20%
Return on Assets (ROA)-0.16%-1.54%-4.08%-6.73%-6.91%-32.31%
Return on Capital Employed (ROCE)-0.30%-3.10%-6.60%-13.20%-12.10%-53.60%
Earnings Yield-1.17%-2.02%-3.46%-1.64%-1.92%-11.99%
FCF Yield-2.62%-0.86%1.42%-0.07%-1.88%-9.62%
Buyback Yield / Dilution-1.14%-0.71%-2.25%-6.94%-7.59%-60.19%